Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06174727 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

Study acronym: IRF
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 2 of 10 entries Show 7 more changesShow less
    • Trial arms changed: 0 → 2
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description expanded, about 15 words
    • Site details revised at 1 of 13 sites
    • Collaborators: details revised at 1 of 13 entries
    • Publications: details revised at 6 of 6 entries
  2. Primary and study completion pushed from Jun 2026 to Jul 2027
    • Study sites: 11 to 13
    • Collaborators: 5 to 13
    • Eligibility criteria expanded, about 1 word
    v5
  3. Study sites: 1 to 11
    • Primary and study completion dates: Dec 2025 to Jun 2026
    • Eligibility criteria expanded, about 12 words
    v4
  4. Primary and study completion dates: Dec 2024 to Dec 2025v3 Show 6 more changesShow less
    • Primary endpoints: 6 to 10
    • Eligibility criteria expanded, about 74 words
    • Secondary endpoints expanded, about 13 words
    • Study description shortened, about 10 words
    • Collaborators expanded, about 14 words
    • Study title expanded, about 3 words
  5. Study title shortened, about 1 wordv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.
Trial Details
NCT Number NCT06174727
Lead Sponsor Montefiore Medical Center
Collaborators: Mayo Clinic, Sarasota Memorial Health Care System, Geisinger Health, University at Buffalo, Thomas Jefferson University, University Health Network, Toronto, Munson Medical Center, HCA Houston Healthcare Kingwood, University of Miami, Robert Wood Johnson University Hospital, Lahey Hospital & Medical Center, Unity Health Toronto, Allina Health System
Conditions
(from sponsor)		 Intracranial Aneurysm
Related terms Intracranial Aneurysm
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov